Choose and Use Your Chemical Probe Wisely to Explore Cancer Biology

被引:133
作者
Blagg, Julian [1 ]
Workman, Paul [1 ]
机构
[1] Inst Canc Res, Canc Res UK Canc Therapeut Unit, Sutton SM2 5NG, Surrey, England
关键词
ASSAY INTERFERENCE COMPOUNDS; SMALL-MOLECULE; DRUG DISCOVERY; IN-VITRO; KINASE INHIBITORS; PROTEIN-KINASE; MEDICINAL CHEMISTRY; TARGET VALIDATION; DRUGGABLE GENOME; BET BROMODOMAINS;
D O I
10.1016/j.ccell.2017.06.005
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Small-molecule chemical probes or tools have become progressively more important in recent years as valuable reagents to investigate fundamental biological mechanisms and processes causing disease, including cancer. Chemical probes have also achieved greater prominence alongside complementary biological reagents for target validation in drug discovery. However, there is evidence of widespread continuing misuse and promulgation of poor-quality and insufficiently selective chemical probes, perpetuating a worrisome and misleading pollution of the scientific literature. We discuss current challenges with the selection and use of chemical probes, and suggest how biologists can and should be more discriminating in the probes they employ.
引用
收藏
页码:9 / 25
页数:17
相关论文
共 127 条
  • [41] Extance A., 2015, COMMUNICATION 1207
  • [42] Targeting bromodomains: epigenetic readers of lysine acetylation
    Filippakopoulos, Panagis
    Knapp, Stefan
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2014, 13 (05) : 339 - 358
  • [43] Selective inhibition of BET bromodomains
    Filippakopoulos, Panagis
    Qi, Jun
    Picaud, Sarah
    Shen, Yao
    Smith, William B.
    Fedorov, Oleg
    Morse, Elizabeth M.
    Keates, Tracey
    Hickman, Tyler T.
    Felletar, Ildiko
    Philpott, Martin
    Munro, Shonagh
    McKeown, Michael R.
    Wang, Yuchuan
    Christie, Amanda L.
    West, Nathan
    Cameron, Michael J.
    Schwartz, Brian
    Heightman, Tom D.
    La Thangue, Nicholas
    French, Christopher A.
    Wiest, Olaf
    Kung, Andrew L.
    Knapp, Stefan
    Bradner, James E.
    [J]. NATURE, 2010, 468 (7327) : 1067 - 1073
  • [44] Discovery of a Potent and Selective EGFR Inhibitor (AZD9291) of Both Sensitizing and T790M Resistance Mutations That Spares the Wild Type Form of the Receptor
    Finlay, M. Raymond V.
    Anderton, Mark
    Ashton, Susan
    Ballard, Peter
    Bethel, Paul A.
    Box, Matthew R.
    Bradbury, Robert H.
    Brown, Simon J.
    Butterworth, Sam
    Campbell, Andrew
    Chorley, Christopher
    Colclough, Nicola
    Cross, Darren A. E.
    Currie, Gordon S.
    Grist, Matthew
    Hassall, Lorraine
    Hill, George B.
    James, Daniel
    James, Michael
    Kemmitt, Paul
    Klinowska, Teresa
    Lamont, Gillian
    Lamont, Scott G.
    Martin, Nathaniel
    McFarland, Heather L.
    Mellor, Martine J.
    Orme, Jonathon P.
    Perkins, David
    Perkins, Paula
    Richmond, Graham
    Smith, Peter
    Ward, Richard A.
    Waring, Michael J.
    Whittaker, David
    Wells, Stuart
    Wrigley, Gail L.
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (20) : 8249 - 8267
  • [45] Structure of the DDBI-CRBN E3 ubiquitin ligase in complex with thalidomide
    Fischer, Eric S.
    Boehm, Kerstin
    Lydeard, John R.
    Yang, Haidi
    Stadler, Michael B.
    Cavadini, Simone
    Nagel, Jane
    Serluca, Fabrizio
    Acker, Vincent
    Lingaraju, Gondichatnahalli M.
    Tichkule, Ritesh B.
    Schebesta, Michael
    Forrester, William C.
    Schirle, Markus
    Hassiepen, Ulrich
    Ottl, Johannes
    Hild, Marc
    Beckwith, Rohan E. J.
    Harper, J. Wade
    Jenkins, Jeremy L.
    Thomae, Nicolas H.
    [J]. NATURE, 2014, 512 (7512) : 49 - +
  • [46] Drug discovery in academia: the third way?
    Frearson, Julie
    Wyatt, Paul
    [J]. EXPERT OPINION ON DRUG DISCOVERY, 2010, 5 (10) : 909 - 919
  • [47] US academic drug discovery
    Frye, Stephen
    Crosby, Marina
    Edwards, Teresa
    Juliano, Rudolph
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2011, 10 (06) : 409 - 410
  • [48] Tackling reproducibility in academic preclinical drug discovery
    Frye, Stephen V.
    Arkin, Michelle R.
    Arrowsmith, Cheryl H.
    Conn, P. Jeffrey
    Glicksman, Marcie A.
    Hull-Ryde, Emily A.
    Slusher, Barbara S.
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2015, 14 (11) : 733 - 734
  • [49] The art of the chemical probe
    Frye, Stephen V.
    [J]. NATURE CHEMICAL BIOLOGY, 2010, 6 (03) : 159 - 161
  • [50] Improving CRISPR-Cas nuclease specificity using truncated guide RNAs
    Fu, Yanfang
    Sander, Jeffry D.
    Reyon, Deepak
    Cascio, Vincent M.
    Joung, J. Keith
    [J]. NATURE BIOTECHNOLOGY, 2014, 32 (03) : 279 - 284